Literature DB >> 663824

Hepatic metabolism in patients with alcoholic cirrhosis.

F A Reichle, O E Owen, M Golsorkhi, T Kreulen.   

Abstract

Fuel homeostasis was studied in 15 patients with hepatic cirrhosis who previously had sustained upper gastrointestinal hemorrhage secondary to portal hypertension. By combining substrate arteriovenous concentration differences with measured hepatic blood flow rates, the exchange rates of metabolites across the liver was calculated. Hepatic extraction of acetoacetate, beta-hydroxybutyrate, lactate, pyruvate, analine, and glycerol was studied. After an overnight fast, splanchnic glucose production in 15 cirrhotic patients was diminished markedly. Despite reduced total glucose production, there was no decrease in hepatic gluconeogenesis; instead, there was increased glucose formation from amino acids, glycerol, lactate, and pyruvate. In patients with hepatic cirrhosis, the liver does not produce as much glucose as does a normal liver; the failing cirrhotic liver is capable of maintaining fuel homeostasis by increased ketone-body production.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 663824

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  3 in total

1.  Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis.

Authors:  O E Owen; F A Reichle; M A Mozzoli; T Kreulen; M S Patel; I B Elfenbein; M Golsorkhi; K H Chang; N S Rao; H S Sue; G Boden
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

2.  Glycerol clearance in alcoholic liver disease.

Authors:  D G Johnston; K G Alberti; R Wright; P G Blain
Journal:  Gut       Date:  1982-04       Impact factor: 23.059

3.  Sarcopenia and a physiologically low respiratory quotient in patients with cirrhosis: a prospective controlled study.

Authors:  Cathy Glass; Peggy Hipskind; Cynthia Tsien; Steven K Malin; Takhar Kasumov; Shetal N Shah; John P Kirwan; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2013-01-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.